Related Experiment Video
Updated: Feb 28, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
How I use laboratory monitoring of antiplatelet therapy
Alan D Michelson1, Deepak L Bhatt2
1Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, and.
Insights
Patients with aspirin or clopidogrel resistance may not benefit from dose adjustments guided by platelet function tests. Current evidence does not support using these tests to personalize antiplatelet therapy.
Area of Science:
- Cardiovascular Medicine
- Hematology
Background:
- Antiplatelet therapy is crucial for managing coronary artery disease and other conditions.
- Aspirin and clopidogrel are widely used antiplatelet agents.
- The concept of 'resistance' to these drugs is a common clinical concern.
Observation:
- This review examines platelet function, drug targets, and clinical uses of antiplatelet agents.
- It addresses the question of patient resistance to aspirin and clopidogrel.
- The article analyzes whether platelet function tests should guide therapy, considering two clinical cases.
Findings:
- Available evidence does not support using laboratory tests to guide aspirin or clopidogrel dosage in patients with apparent resistance.
- The clinical benefit of tailoring antiplatelet therapy based on resistance testing remains controversial.
Implications:
- Current guidelines and evidence do not endorse routine platelet function testing for dose adjustment of aspirin or clopidogrel.
- Further research may be needed to clarify the role and clinical utility of antiplatelet resistance testing.
Abstract:
Antiplatelet therapy is of proven benefit in coronary artery disease and a number of other clinical settings. This article reviews platelet function, molecular targets of antiplatelet agents, and clinical indications for antiplatelet therapy before focusing on a frequent question to hematologists about the 2 most commonly used antiplatelet therapies: Could the patient be aspirin "resistant" or clopidogrel "resistant"? If so, should results of a platelet function test be used to guide the dose or type of antiplatelet therapy? Whether such guided therapy is of clinical benefit to patients has been a source of controversy. The present article reviews this subject in the context of 2 prototypical clinical cases. Available evidence does not support the use of laboratory tests to guide the dose of aspirin or clopidogrel in patients with so-called aspirin or clopidogrel "resistance."
More Related Videos
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

